GLP-1 Drugs Work.
Muscle Loss Doesn't Have To.
40% of the weight you lose on Ozempic or Mounjaro can be lean muscle — not fat. Here's the science behind why, and what the evidence actually supports for preventing it.
The muscle-loss problem in three numbers
Recent articles
BPC-157: The Science Behind the Most Researched Gut and Connective Tissue Peptide
What the preclinical literature shows about BPC-157: gut healing, connective tissue repair, angiogenesis mechanisms, and the July 2026 FDA regulatory review.
CJC-1295 and Ipamorelin: What the Research Shows About GH Synergy
CJC-1295 and ipamorelin activate two separate GH-release pathways. Research since 1990 documents their combination produces substantially more GH than either alone.
What Is an Epigenetic Age Test? The Science Behind Biological Age Tracking
TruDiagnostic's TruAge measures DNA methylation to estimate biological age. Here's what the science shows — and why it matters for GLP-1 users.
GLP-1 Muscle Loss: The Science + What You Can Actually Do About It
GLP-1 drugs cause 40–45% lean mass loss on average. Here's the science behind why — and the evidence-based strategies most worth your attention.
Free: GLP-1 Muscle Protocol Checklist
The research-backed moves that actually reduce lean mass loss on GLP-1 therapy — protein targets, lifting minimums, what to track, and when. One email. No spam.
We respect your privacy. No spam, ever.